KUKJEON PHARMACEUTICAL CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,640 KRW | -1.05% |
|
+2.73% | -9.62% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 537,308 | 324,839 | 306,192 |
| Enterprise Value (EV) 1 | 505,901 | 289,207 | 320,139 |
| P/E ratio | 120 x | 583 x | 63.7 x |
| Yield | - | - | 0.16% |
| Capitalization / Revenue | 6.3 x | 3.13 x | 2.51 x |
| EV / Revenue | 5.93 x | 2.79 x | 2.62 x |
| EV / EBITDA | 70.1 x | 58.6 x | 33.2 x |
| EV / FCF | - | -28,843,306 x | -7,849,148 x |
| FCF Yield | - | -0% | -0% |
| Price to Book | 6.46 x | 3.55 x | 3.18 x |
| Nbr of stocks (in thousands) | 49,069 | 49,069 | 49,069 |
| Reference price 2 | 10,950 | 6,620 | 6,240 |
| Announcement Date | 3/21/23 | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 85,354 | 103,711 | 121,998 |
| EBITDA 1 | 7,215 | 4,932 | 9,643 |
| EBIT 1 | 6,109 | 3,488 | 6,509 |
| Operating Margin | 7.16% | 3.36% | 5.34% |
| Earnings before Tax (EBT) 1 | 5,084 | 11,088 | 1,738 |
| Net income 1 | 4,038 | 8,948 | 4,824 |
| Net margin | 4.73% | 8.63% | 3.95% |
| EPS 2 | 91.00 | 11.35 | 98.00 |
| Free Cash Flow | - | -10,027 | -40,786 |
| FCF margin | - | -9.67% | -33.43% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | 10.00 |
| Announcement Date | 3/21/23 | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | - | - | 13,947 |
| Net Cash position 1 | 31,407 | 35,632 | - |
| Leverage (Debt/EBITDA) | - | - | 1.446 x |
| Free Cash Flow | - | -10,027 | -40,786 |
| ROE (net income / shareholders' equity) | - | 10.1% | 4.94% |
| ROA (Net income/ Total Assets) | - | 1.44% | 1.93% |
| Assets 1 | - | 622,026 | 249,733 |
| Book Value Per Share 2 | 1,695 | 1,867 | 1,965 |
| Cash Flow per Share 2 | 389.0 | 439.0 | 224.0 |
| Capex 1 | 10,409 | 23,285 | 43,923 |
| Capex / Sales | 12.19% | 22.45% | 36% |
| Announcement Date | 3/21/23 | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -9.62% | 204M | |
| +19.98% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +44.72% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B | |
| -2.27% | 4.81B |
- Stock Market
- Equities
- A307750 Stock
- Financials KUKJEON PHARMACEUTICAL Co., Ltd
